Creatine Kinase-MB

American Journal of Clinical Pathology

Volumn 141, Issue 3, 2014, Pages 415-419

  Singh, Gurmukh ^a,b   Baweja, Paramdeep S ^a  

^a TRUMAN MEDICAL CENTER   (United States)

^b Heritage Laboratories International Inc   (United States)

Author keywords

Acute coronary syndrome; CK MB; Obsolete laboratory tests; Troponin

Indexed keywords

CREATINE KINASE MB; TROPONIN I; TROPONIN T; TROPONIN;

ACUTE CORONARY SYNDROME; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; DIAGNOSTIC VALUE; HUMAN; LABORATORY DIAGNOSIS; LABORATORY TEST; MAJOR CLINICAL STUDY; MEDICAL RECORD; PERSONAL EXPERIENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; CK-MB; DIAGNOSTIC TEST; HEART INFARCTION; HOSPITAL LABORATORY; OBSOLETE LABORATORY TESTS; UTILIZATION REVIEW;

ACUTE CORONARY SYNDROME; CK-MB; OBSOLETE LABORATORY TESTS; TROPONIN;

ACUTE CORONARY SYNDROME; CREATINE KINASE, MB FORM; DIAGNOSTIC TESTS, ROUTINE; HUMANS; LABORATORIES, HOSPITAL; MYOCARDIAL INFARCTION;

EID: 84897944144     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPBIK3G4BWEJKO     Document Type: Article

References (20)

1. Jaffe AS, Babuin L, Apple FS. Biomarkers in acute cardiac disease: the present and the future. J Am Coll Cardiol. 2006;48:1-11.
2. Eggers KM, Oldgren J, Nordenskjold A, et al. Diagnostic value of serial measurements of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. Am Heart J. 2004;148:574-581.
3. Pincus MR, Abraham NZ, Carty RP. Clinical enzymology. In: McPherson RA, Pincus MR, eds. Henry's Clinical Diagnosis and Management by Laboratory Methods. New York, NY: Elsevier; 2011:273-295.
4. Apple FS, Saenger AK. The state of cardiac troponin assays: looking bright and moving in the right direction. Clin Chem. 2013;59:1014-1016.
5. College of American Pathologists (CAP). Cardiac Proficiency Testing Survey, CAR-B. Northfield, IL: CAP; 2013.
6. McCann CJ, Glover BM, Menown BA, et al. Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain. Am J Cardiol. 2009;103:22-28.
7. Lindahl B. Multimarker approach for diagnosis of acute myocardial infarction: better answers need better questions. Clin Chem. 2009; 55:9-11.
8. Zimmerman J, Fromm R, Meyer D, et al. Diagnostic Marker Cooperative Study for the diagnosis of myocardial infarction. Circulation. 1999;99:1671-1677.
9. Collinson PO, van Dieijen-Visser MP, Pulkki K, et al. Evidence-based laboratory medicine: how well do laboratories follow recommendations and guidelines? The Cardiac Marker Guideline Uptake in Europe (CARMAGUE) study. Clin Chem. 2012;58:305-306.
10. Kiechle FL, Arcenas RC, Rogers lLC. Establishing benchmarks and metrics for disruptive technologies, inappropriate and obsolete tests in clinical laboratory. Clin Chim Acta. 2014;427:131-136.
11. Warren JS. Laboratory test utilization program: structure and impact in a large academic medical center. Am J Clin Pathol. 2013;139:289-297.
12. Apple FS, Collinson PO. Analytical characteristics of highsensitivity cardiac troponin assays. Clin Chem. 2012;58:54-61.
13. McKie PM, Heublein DN, Scott CG, et al. Defining high-sensitivity cardiac troponin concentrations in the community. Clin Chem. 2013;59:1099-1107.
14. Lin JC, Apple FS, Murakami MM, et al. Rates of positive cardiac troponin I and creatine kinase MN mass among patients hospitalized for suspected acute coronary syndromes. Clin Chem. 2004;50:333-338.
15. Newby LK, Roe MT, Chen AY, et al. Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes. J Am Coll Cardiol. 2006;47:312-318.
16. Bingisser R, Cairns C, Christ M, et al. Cardiac troponin: a critical review of the case for point-of-care testing in the ED. Am J Emerg Med. 2012;30:1639-1649.
17. Jaffe AS, Apple FS, Lindahl B, et al. Why all the struggle about CK-MB and PCI? Eur Heart J. 2012;33:1046-1048.
18. Zimarino M, Cicchitti V, Genovesi E, et al. Isolated troponin increase after percutaneous coronary intervention: does it have prognostic relevance? Atherosclerosis. 2012;221:297-302.
19. Saenger AK, Jaffe JS. Requiem for a heavy weight: the demise of creatine kinase-MB. Circulation. 2008;118:2200-2206.
20. Barron JM, Lewandrowksi KB, Kamis IK, et al. A novel strategy for evaluating effects of an electronic test ordering alert message: optimizing cardiac marker use. J Pathol Inform. 2012;3:3.